Search results
Results From The WOW.Com Content Network
(Reuters) - Indian drugmaker Mankind Pharma said late on Thursday it would acquire Bharat Serums and Vaccines Ltd in a deal valued at around 136.30 billion rupees ($1.63 billion), including debt.
Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company based in Hyderabad, which is engaged in drug discovery, drug development, and the manufacture of vaccines, biotherapeutics, pharmaceuticals and healthcare products.
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.
Bharat Biotech is the first in the world to find a vaccine for the Zika virus. [9] [10] Bharat Biotech has delivered over 4 billion vaccines in 123 countries. [4] The vaccine against COVID-19 developed by Bharat Biotech, named Covaxin, was endorsed by the Indian government with an active push by the⠀Indian Prime Minister Narendra Modi. [11]
India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...
In 2024, Mankind Pharma acquired a 100% stake in Bharat Serums and Vaccines (BSV) from private equity firm Advent International for an enterprise value of ₹ 13,630 crore (US$1.6 billion). [31] The deal included over 2,500 employees joining the company.
Serum Institute of India also reached an agreement with Novavax for the production of Novavax's NVX-CoV2373 (Covovax) vaccine for India and other low and middle-income countries. [31] [32] The company would also produce Codagenix's nasally administered COVID-19 vaccine CDX-005 [33] [34] (tradename COVI-VAC). [35]
India has approved a monoclonal formulation called Rhoclone (Bharat Serums and Vaccines Ltd.), [31] made from hybridoma cultures. The country has also tested and recently marketed a recombinant version of Rhoclone expressed in CHO cells. [32]